Revisión
Biomarcadores de pronóstico en pacientes con cáncer de próstata localizado
Prognostic biomarkers in patients with localised prostate cancer
Natalia Acostaa,
, Rodolfo Varelab,c, Jorge Andrés Mesad, Martha Lucía Serrano Lópeza,e, Alba Lucía Cómbitaa,f, María Carolina Sanabria-Salasa
Autor para correspondencia
a Grupo de Investigación en Biología del Cáncer, Subdirección General de Investigaciones, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
b Clínica de Urología, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
c Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D. C., Colombia
d Grupo de Patología Oncológica, Subdirección General de Atención Médica y Docencia, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
e Departamento de Química, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá D. C., Colombia
f Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D. C., Colombia
Leído
10618
Vecesse ha leído el artículo
1190
Total PDF
9428
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 13 | 4 | 17 |
| 2025 11 | 114 | 22 | 136 |
| 2025 10 | 75 | 14 | 89 |
| 2025 9 | 48 | 18 | 66 |
| 2025 8 | 67 | 14 | 81 |
| 2025 7 | 78 | 7 | 85 |
| 2025 6 | 70 | 4 | 74 |
| 2025 5 | 88 | 5 | 93 |
| 2025 4 | 86 | 9 | 95 |
| 2025 3 | 91 | 4 | 95 |
| 2025 2 | 66 | 6 | 72 |
| 2025 1 | 95 | 1 | 96 |
| 2024 12 | 110 | 6 | 116 |
| 2024 11 | 95 | 3 | 98 |
| 2024 10 | 102 | 13 | 115 |
| 2024 9 | 86 | 9 | 95 |
| 2024 8 | 90 | 6 | 96 |
| 2024 7 | 101 | 3 | 104 |
| 2024 6 | 100 | 6 | 106 |
| 2024 5 | 91 | 6 | 97 |
| 2024 4 | 119 | 4 | 123 |
| 2024 3 | 99 | 5 | 104 |
| 2024 2 | 127 | 13 | 140 |
| 2024 1 | 124 | 8 | 132 |
| 2023 12 | 115 | 10 | 125 |
| 2023 11 | 105 | 29 | 134 |
| 2023 10 | 143 | 30 | 173 |
| 2023 9 | 62 | 18 | 80 |
| 2023 8 | 75 | 20 | 95 |
| 2023 7 | 108 | 15 | 123 |
| 2023 6 | 102 | 10 | 112 |
| 2023 5 | 135 | 15 | 150 |
| 2023 4 | 123 | 6 | 129 |
| 2023 3 | 110 | 9 | 119 |
| 2023 2 | 78 | 1 | 79 |
| 2022 1 | 78 | 11 | 89 |
| 2022 12 | 93 | 12 | 105 |
| 2022 11 | 77 | 13 | 90 |
| 2022 10 | 88 | 14 | 102 |
| 2022 9 | 69 | 20 | 89 |
| 2022 8 | 62 | 13 | 75 |
| 2022 7 | 64 | 8 | 72 |
| 2022 6 | 80 | 11 | 91 |
| 2022 5 | 63 | 12 | 75 |
| 2022 4 | 74 | 15 | 89 |
| 2022 3 | 100 | 11 | 111 |
| 2022 2 | 70 | 9 | 79 |
| 2021 1 | 89 | 13 | 102 |
| 2021 12 | 90 | 10 | 100 |
| 2021 11 | 140 | 15 | 155 |
| 2021 10 | 125 | 21 | 146 |
| 2021 9 | 102 | 24 | 126 |
| 2021 8 | 121 | 9 | 130 |
| 2021 7 | 107 | 8 | 115 |
| 2021 6 | 120 | 13 | 133 |
| 2021 5 | 143 | 5 | 148 |
| 2021 4 | 279 | 11 | 290 |
| 2021 3 | 178 | 15 | 193 |
| 2021 2 | 101 | 12 | 113 |
| 2020 1 | 103 | 10 | 113 |
| 2020 12 | 121 | 26 | 147 |
| 2020 11 | 173 | 19 | 192 |
| 2020 10 | 99 | 8 | 107 |
| 2020 9 | 106 | 24 | 130 |
| 2020 8 | 99 | 12 | 111 |
| 2020 7 | 98 | 9 | 107 |
| 2020 6 | 115 | 24 | 139 |
| 2020 5 | 87 | 10 | 97 |
| 2020 4 | 88 | 9 | 97 |
| 2020 3 | 438 | 8 | 446 |
| 2020 2 | 97 | 13 | 110 |
| 2020 1 | 90 | 15 | 105 |
| 2019 12 | 38 | 15 | 53 |
| 2019 11 | 42 | 11 | 53 |
| 2019 10 | 61 | 13 | 74 |
| 2019 9 | 65 | 7 | 72 |
| 2019 8 | 48 | 3 | 51 |
| 2019 7 | 58 | 27 | 85 |
| 2019 6 | 126 | 11 | 137 |
| 2019 5 | 247 | 19 | 266 |
| 2019 4 | 138 | 22 | 160 |
| 2019 3 | 37 | 9 | 46 |
| 2019 2 | 44 | 10 | 54 |
| 2019 1 | 29 | 10 | 39 |
| 2018 12 | 18 | 4 | 22 |
| 2018 11 | 38 | 9 | 47 |
| 2018 10 | 62 | 7 | 69 |
| 2018 9 | 36 | 10 | 46 |
| 2018 8 | 36 | 4 | 40 |
| 2018 7 | 67 | 8 | 75 |
| 2018 6 | 57 | 4 | 61 |
| 2018 5 | 88 | 13 | 101 |
| 2018 4 | 259 | 4 | 263 |
| 2018 3 | 29 | 1 | 30 |
| 2018 2 | 32 | 6 | 38 |
| 2018 1 | 27 | 8 | 35 |
| 2017 12 | 23 | 2 | 25 |
| 2017 11 | 35 | 3 | 38 |
| 2017 10 | 45 | 6 | 51 |
| 2017 9 | 34 | 5 | 39 |
| 2017 8 | 31 | 3 | 34 |
| 2017 7 | 35 | 8 | 43 |
| 2017 6 | 6 | 15 | 21 |
| 2017 5 | 5 | 10 | 15 |
| 2017 4 | 1 | 11 | 12 |
| 2017 3 | 5 | 20 | 25 |
| 2017 2 | 2 | 13 | 15 |
| 2016 1 | 1 | 3 | 4 |
| 2016 12 | 5 | 11 | 16 |
Mostrar todo
